Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
37.00
Nov 20 • 3:59 PM ET Dollar change-0.81 Percentage change(-2.14%)
Aftermarket Close
36.02
Aftermarket • 7:30 PM ET Dollar change-0.98 Percentage change(-2.65%)
Category
Global or ExUS Equities - Industry Sector
Sponsor
Blackrock (iShares)
Fund Family
Index
NYSE FactSet Global Genomics and Immuno...
Index Weighting
Active/Passive
Expense
0.47%
Inverse/Leveraged
IPO
Jun 13, 2019
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
Tags
Tags
-
Sector/Theme
Region
SMA20
-10.28%
SMA50
-10.14%
SMA200
8.42%
Return% 1Y
44.09%
Return% 3Y
25.05%
Return% 5Y
-4.19%
Return% 10Y
Return% SI
Flows% 1M
11.68%
Flows% 3M
39.49%
Flows% YTD
70.50%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
63
AUM
320.11M
NAV/sh
52W High
44.15 -16.19%
52W Low
25.82 43.30%
Volatility
2.90% 3.10%
ATR (14)
1.31
RSI (14)
33.42
Beta
0.99
Rel Volume
1.66
Avg Volume
177.07K
Volume
293,878
Perf Week
-7.73%
Perf Month
-9.84%
Perf Quarter
-6.73%
Perf Half Y
25.64%
Perf YTD
41.28%
Perf Year
43.24%
Perf 3Y
80.31%
Perf 5Y
-22.43%
Perf 10Y
-
Prev Close
37.81
Price
37.00
Change %
-2.14%
iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma IndexTM. The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.